SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 9.980+4.1%Oct 31 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (537)6/10/2008 1:52:30 AM
From: Mike McFarlandRead Replies (1) of 557
 
(said nothing about the vaccine work)

I have nothing new, but since I was poking around
I'll park this here, something to do with their
hiv vaccine work

claims
wipo.int

Actually, the description tab is sorta interesting
reading.
wipo.int
When the boost dose is administered by a rAAV vector, a single antigen of the pathogen may be administered with a single rAAV that encodes the antigen; two or multiple antigens of the pathogen may be administered with a single rAAV vector that encodes the two: or multiple antigens; or two or multiple antigens may be administered with two or multiple rAAV vectors the encode the antigens. When rAAV is used for boost, it is given as a single administration


I don't see which of the tgen patents this one is
associated with, but there is a list here
patentstorm.us

Everytime I tell myself I am stopped out of this
awful stock, I find a reason just to move my mental
stop down again, ha. It isn't actually funny how
much I've lost on biotechs these past couple years,
but at least I can afford the losses. I guess I am
a little shellshocked that tgen has only a marketcap
of $14M. You would not think that they could manage several
different programs and that the cash will last for very
long, but on the other hand you have to think that it would
be a very trivial buyout possibility for any number of
biotech companies--even the small biotechs that have a
marketcap less than a billion could absorb tgen very easily
and have several interesting projects for cheap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News